PSU IN MEDIA
Will not sell BCPL HAL to foreign companies Govt
NEW DELHI .Govt on Friday said it will not sell sick pharma Public Sector Udertakings (PSUs) — Bengal Chemicals and Pharmaceuticals (BCPL) and Hindustan Antibiotics (HAL) — to foreign firms and closure of Indian Drugs and Pharmaceuticals (IDPL) and Rajasthan Drugs & Pharmaceuticals (RDPL) will not affect domestic capacities.
There will not be any shortage of medicines in the country because of this move, Minister of State for Fertiliser Mansukh L Mandaviya said, adding the domestic pharma industry was growing at an over 12 per cent per annum rate and the government has come out with several schemes to provide drugs and medical devices at affordable rates.
During Question Hour in Rajya Sabha, some members of Congress, Communist Party of India (CPI), CPI(M) and Dravida Munnetra Kazhagam voiced concern over the government's decision to sell BCPL and HAL and closing down of IDPL and RDPL. Business-standard
Read Also : Indian Air Force ushers in Digital Transformation with DigiLocker Integration
News Must Read
- NCL General Manager (Finance) D Sunil Kumar recommended for SECL Director (Finance)
- Bank of Maharashtra Q4 results, Net Profit increased by 44.95 percent to Rs 1,218 crore
- Axis Bank Overtakes Kotak Mahindra Bank to Become India's Fourth Most Valued Lender
- LIC cuts stakes in major PSU stocks
- SJVN CMD Geeta Kapur Inaugurates Construction Works at Sunni Dam Project in Himachal Pradesh
- PESB Selects R Veerabahu as Director (Finance) for Braithwaite & Co. Limited
- Grew Energy bags largest order of 200 MW Contract of SECI's Auction
- CPCL Reports 39% YoY Drop in Q4 Net Profit, Declares Rs 55 per Share Dividend
- SJVN Limited inaugurates India's first Multi-purpose Green Hydrogen Pilot Project
- KRDCL, RVNL JV emerges as the Lowest Bidder for Redevelopment of Thiruvananthapuram Central Railway Station